Steven Davidoff Solomon writes for The New York Times, Oct. 27, 2015
The recent turmoil in the shares of Valeant Pharmaceuticals International reveals a dangerous tendency of these funds to engage in herd behavior, following the crowd as they plunge in and out of a stock.